Company involving high tech, life sciences and biotech
Austrianova is one business that does things that contains high tech, life sciences and biotech. It is accompanied with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based firm that concentrate in the attachment of living cells or bacteria in little pills for shield which is also recognized as cell encapsulation technology, isolation, storage and transportation. We were first created in the year 2007 and was based in Singapore's well-known study biotech hub, Biopolis that has large-scale goal in offering encapsulation packages like micro encapsulation.
There is a fast increasing area of liking in healthy care and more detailed, in the subject of neutraceuticals which is the knowing and use of probiotic bacteria. So, probiotics encapsulation was created. The cell-in-a-box technology was developed by Austranova with the target to keep safe, separate, collect and move living cells. This proprietary skill can be used for numerous reasons and can be applied to probiotics, cosmetics and agriculture environmental protection and screening as well as developing the basis of a powerful research tool.
In healthcare, this skill assists controloperate secure embedding of cells or stem cells such as cell therapy, holding them alone from the immune system and enabling long term production of therapeutic molecules in patients. In biotechnology, the cell-in-a-box skill protects cells in bioreactors and fermentors and at the same time, it simplifies cleansing of bioproducts produced from the cells and it cut down manufacture price too.
A large ruler cGMP facility for the production of biomedical grade encapsulated cell items was actually effectively constructed and right now, Austrianova is in the journey of developing this ability in the whole of SE Asia. This means the use of cell-in-a-box was quite a accomplishment for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to enable minor dosages of chemotherapy to be used more efficaciously without the casual enervating side outcomes. The encapsulated cell are sited, using supraselective catheterisation, into blood vessels that leads to the tumor where they locally alter a chemotherapeutic product to its tumor toxic product.
Come to our web for additional information: Capsules, Micro Encapsulation, Cell Encapsulation Technology.
